A concept taxonomy and an instrument hierarchy: Tools for establishing and evaluating the conceptual framework of a patient-reported outcome (pro) instrument as applied to product labeling claims

Value in Health

Volumn 12, Issue 8, 2009, Pages 1158-1167

  Erickson, Pennifer ^a   Willke, Richard ^b   Burke, Laurie ^c  

^a Massachusetts Inst of Technology   (United States)

^b PFIZER INC   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Classification system; Conceptual framework; Patient reported outcomes; PRO concept taxonomy; PRO instrument hierarchy

Indexed keywords

ARTICLE; CLASSIFICATION; CONCEPTUAL FRAMEWORK; DRUG LABELING; FOOD AND DRUG ADMINISTRATION; HEALTH ASSESSMENT QUESTIONNAIRE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PATIENT REPORTED OUTCOME; PRESCRIPTION; PRIORITY JOURNAL; SELF REPORT; TAXONOMY; UNITED STATES;

EID: 70350783886     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2009.00609.x     Document Type: Article

References (46)

1. US Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims, draft guidance. February 2006.
2. Bush JW. General health policy model/Quality of Well-Being (QWB) scale. In : Wenger NK, Mattson ME, Furberg CD, et al., eds., Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York : New York, Le Jacq Publishing, 1984.
3. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990 16 : 199 208.
4. Ware JE, Sherbourne CD. The MOS 36-item Short Form Health Survey (SF-36): I. conceptual framework and item selection. Med Care 1992 30 : 473 483.
5. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963 185 : 914 919.
6. OLGA. The on-line guide to quality-of-life assessment. Available from: http://www.OLGA-QoL.com [Accessed August 20, 2009 I. Measuring Health: A Guide to Rating Scales and Questionnaires (3rd ed.). Oxford, England : Oxford University Press, 2006.
7. Kane RA, Kane RL, Eds. Assessing Older Persons: Measures, Meaning, and Practical Applications. Oxford, England : Oxford University Press, 2000.
8. Turk DC, Melzack R. Handbook of Pain Assessment (2nd ed.). New York, NY : The Guilford Press, 2001.
9. Bech P. Rating Scales for Psychopathology, Health Status and Quality of Life: A Compendium on Documentation in Accordance with the DSM-III-R and WHO Systems. Berlin, Germany : Springer-Verlag, 1993.
10. Frank-Stromberg M, Ed. Instruments for Clinical Health-Care Research (3rd ed.). Boston, MA : Jones and Bartlett Publishers, 2004.
11. Fries JF. The hierarchy of quality-of-life assessment, the Health Assessment Questionnaire (HAQ), and issues mandating development of a toxicity index. Control Clin Trials 1991 12 (Suppl. 4 106S 17S.
12. Guyatt GH, Jaeschke R, Feeny DH, Patrick DL. Measurements in clinical trials: choosing the right approach. In : Spilker B, ed., Quality of Life and Pharmacoeconomics in Clinical Trials (2nd ed.). Philadelphia, PA : Lippincott-Raven Press, 1996.
13. Spilker B, Revicki DA. Taxonomy of quality of life. In : Spilker B, ed., Quality of Life and Pharmacoeconomics in Clinical Trials (2nd ed.). Philadelphia, PA : Lippincott-Raven Press, 1996.
14. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (4th ed., Text Revision). Washington, DC : American Psychiatric Association, 2000.
15. International Statistical Classification of Diseases and Related Health Problems (10th Revision, Version for 2007). Available from: http://www.who.int/ classifications/apps/icd/icd10online [Accessed August 20, 2009].
16. International Classification of Functioning, Disability, and Health. Available from: http://www.who.int/classifications/icf/en [Accessed August 20, 2009].
17. Verhoeff J, Toussaint PJ, Zwetsloot-Schonk JHM, et al. Effectiveness of the introduction of an International Classification of Functioning, Disability and Health-based Rehabilitation Tool in Multidisciplinary Team Care in patients with rheumatoid arthritis. Arthritis Rheum 2007 57 : 240 248.
18. Kennedy C. Functioning and disability associated with mental disorders: the evolution since ICIDH. Disabil Rehabil 2003 25 : 611 619.
19. Willke R, Burke LB, Erickson P. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved labels. Control Clin Trials 2004 25 : 535 552.
20. Guidance for industry and review staff: target product profile - a strategic development process tool: draft guidance. Available from: http://www.fda.gov/downloads/Drug/Guidance/Compliance/RegulatoryInformation/ Guidances/ucm080593 [Accessed August 20, 2009].
21. Erickson P, Scott J. Guide to Quality-of-Life Assessment (OLGA): a resource for selecting quality-of-life assessments. In : Walker S, Rosser R, eds., Quality of Life Assessment: Key Issues in the 1990s. Boston, MA : Kluwer Academic Publishers, 1993.
22. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the Health Assessment Questionnaire, Disability and Pain Scales. J Rheumatol 1982 9 : 789 793.
23. Patrick DL, Erickson P. Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York, NY : Oxford University Press, 1993.
24. Stewart AL. The medical outcomes study framework of health indicators. In : Stewart AL, Ware JE Jr., eds., Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC : Duke University Press, 1992.
25. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 1995 273 : 59 65.
26. Rothman ML, Beltran P, Cappelleri JC, et al. Patient-reported outcomes: conceptual issues. Value Health 2007 10 (Suppl. 2 S66 75.
27. Patrick DL, Burke LB, Powers JH, et al. Patient-reported outcomes to support medical product labeling claims. Value Health 2007 10 (Suppl. 2 S125 37.
28. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002 11 : 193 205.
29. Blazeby J, Sprangers M, Cull A, et al. Guidelines for developing questionnaire modules. Available from: http://www.groups.eortc.be/qol/ documentation-manuals.htm [Accessed August 20, 2009].
30. Leidy NK, Vernon M. Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment. Pharmacoeconomics 2008 26 : 363 370.
31. Ware JE Jr., Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. conceptual framework and item selection. Med Care 1992 30 : 473 483.
32. Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995 38 : 727 735.
33. Felson DT, Anderson JJ, Lange ML, et al. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? Arthritis Rheum 1998 41 : 1564 1570.
34. Pincus T, Summey JA, Soraci SA Jr., et al. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983 26 : 1346 1353.
35. Rosen RC, Riley A, Wagner G, et al. The International Index of Erectile Dysfunction (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997 49 : 822 830.
36. Lindley CM, Hirsch JD, O'Neill CV, et al. Quality of life consequences of chemotherapy-induced emesis. Qual Life Res 1992 1 : 331 340.
37. Sheehan DV. The Anxiety Disease. New York : Scribner, 1986.
38. Galasko D, Bennett D, Sano M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. Alzheimer Dis Assoc Disord 1997 11 (Suppl. 2 S33 9.
39. Beusterien KM, Rogers AE, Walsleben JA, et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 1999 22 : 757 765.
40. Comella CL, Stebbins GT, Goetz CG, et al. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord 1997 12 : 570 575.
41. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1998 15 : 1833 1840.
42. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 1991 18 : 728 733.
43. Gilson BS, Gilson JS, Bergner M, et al. The sickness impact profile: development of an outcome measure of health care. Am J Public Health 1975 65 : 1304 1310.
44. Aaronson NK, Ahmedza S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993 85 : 365 376.
45. Drugs@FDA. FDA approved drug products. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/ [Accessed August 20, 2009].
46. PDR: Physicians' Desk Reference (Edition 61). Montvale, NJ : Medical Economics Company, 2007.